Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 9Lymphoid 9Myeloid 7Plasma cell 3Other neoplasm 2Classical hematology 2Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 40Anemia, Refractory, with Excess of Blasts 40Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Leukemia, Lymphocytic, Chronic, B-Cell 28Myelodysplastic Syndromes 27Lymphoma, Non-Hodgkin 27Leukemia, Myelomonocytic, Chronic 27Hodgkin Disease 27Multiple Myeloma 24Primary Myelofibrosis 21Myeloproliferative Disorders 21Lymphoma, Follicular 21Leukemia 21Lymphoma 20Lymphoma, Mantle-Cell 19Congenital Abnormalities 19Leukemia, Myeloid, Chronic-Phase 18Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18Anemia, Refractory 18Lymphoma, B-Cell, Marginal Zone 17Burkitt Lymphoma 17Lymphoma, Large B-Cell, Diffuse 16Lymphoma, Large-Cell, Immunoblastic 15Leukemia, Myeloid, Accelerated Phase 15Dendritic Cell Sarcoma, Interdigitating 13Neoplasms, Plasma Cell 12Recurrence 11Blast Crisis 11Anemia, Aplastic 11Leukemia, Myelomonocytic, Juvenile 10

Interventions

Cyclophosphamide 4fludarabine phosphate 2fludarabine 2Stem Cell Transplantation 2Platelet Transfusion 2Mycophenolic Acid 2Mesna 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Bone Marrow Transplantation 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2venetoclax 1cedazuridine 1Thiotepa 1Tacrolimus 1Sertraline 1Rituximab 1Observation 1Methotrexate 1Cyclosporine 1Cholecalciferol 1Brentuximab Vedotin 1Biopsy 1Azacitidine 1Aspirin 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hematologic Diseases × Mycophenolic Acid × Classical hematology × Clear all
NCT05589896 2026-02-24

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

Ossium Health, Inc.

Phase 1/2 Recruiting
12 enrolled
Classical hematologyDermatologicLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Hematologic Diseases, Hodgkin Disease, Leukemia, Lymphoma, Leukemia, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Cutaneous, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01010217 2020-03-25

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

M.D. Anderson Cancer Center

Phase 2 Completed
176 enrolled 18 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hematologic Diseases, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡